NONCOLORIMETRIC MEASUREMENT OF CELL-ACTIVITY IN 3-DIMENSIONAL HISTOCULTURE USING THE TETRAZOLIUM DYE 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE - THE PIXEL IMAGE-ANALYSIS OF FORMAZAN CRYSTALS

被引:10
作者
COLANGELO, D
GUO, HY
CONNORS, KM
SILVESTRO, L
HOFFMAN, RM
机构
[1] RESPHARMA PHARMACOL RES SRL,I-10125 TURIN,ITALY
[2] UNIV CALIF SAN DIEGO,SCH MED,CANC BIOL LAB,LA JOLLA,CA 92093
关键词
D O I
10.1016/0003-2697(92)90571-N
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe a novel system for measuring the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction in three-dimensional histoculture which is no longer dependent on colorimetric determination of extracted formazan, but rather is based on a pixel image analysis of formazan crystals, and which allows intratumor heterogeneity to be taken into account. The MTT test is based on the enzymatic reduction of the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheniltetrazolium bromide to formazan crystals by living, metabolically active cells, but not in dead cells. The reaction was carried out in situ in six-well plates on gel-supported histocultured human tumors. After a 24-h incubation with different drugs the tumors were incubated with a solution of MTT. Frozen sections of the tumor pieces were made and the slides were then stained with a propidium iodide solution, whose fluorescence is proportional to the number of cells present. We demonstrate here that the formazan crystals, formed by MTT reduction, reflect polarized light and that this can be quantified by using an image analysis system based on bright-pixel quantitation directly on a frozen section of the original tissue. Combined with the use of the fluorescent dye propidium iodide, also measured by pixel analysis, we can express a ratio between the total amount of MTT reduction and the total number of cells present in the specimen that expresses the effect of drugs on the histocultured tumors. Since histology is well maintained in histoculture it is possible to take into account the heterogeneity present in the tumor with regard to drug response. This assay system should be of potential clinical use for predicting the drug response of cancer patients. © 1992.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 18 条
[1]  
ALLEY MC, 1988, CANCER RES, V48, P589
[2]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[3]   INVIVO-LIKE GROWTH OF HUMAN-TUMORS INVITRO [J].
FREEMAN, AE ;
HOFFMAN, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2694-2698
[4]   HIGH INVITRO-INVIVO CORRELATION OF DRUG RESPONSE USING SPONGE-GEL-SUPPORTED 3-DIMENSIONAL HISTOCULTURE AND THE MTT END-POINT [J].
FURUKAWA, T ;
KUBOTA, T ;
WATANABE, M ;
TAKAHARA, T ;
YAMAGUCHI, H ;
TAKEUCHI, T ;
KASE, S ;
KODAIRA, S ;
ISHIBIKI, K ;
KITAJIMA, M ;
HOFFMAN, RM .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (03) :489-498
[5]   PRIMARY BIOASSAY OF HUMAN TUMOR STEM-CELLS [J].
HAMBURGER, AW ;
SALMON, SE .
SCIENCE, 1977, 197 (4302) :461-463
[6]  
HEO DS, 1990, CANCER RES, V50, P3681
[7]   A GENERAL NATIVE-STATE METHOD FOR DETERMINATION OF PROLIFERATION CAPACITY OF HUMAN NORMAL AND TUMOR-TISSUES INVITRO [J].
HOFFMAN, RM ;
CONNORS, KM ;
MEERSONMONOSOV, AZ ;
HERRERA, H ;
PRICE, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) :2013-2017
[8]   HIGHLY SPECIFIC PREDICTION OF ANTINEOPLASTIC DRUG-RESISTANCE WITH AN INVITRO ASSAY USING SUPRAPHARMACOLOGIC DRUG EXPOSURES [J].
KERN, DH ;
WEISENTHAL, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) :582-588
[9]  
KUBOTA T, 1986, JPN J CANCER RES, V77, P502
[10]  
LEIGHTON J, 1951, J NATL CANCER I, V12, P545